dihydroxyphenylalanine has been researched along with Osteoporotic Fractures in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Osteoporotic Fractures: Breaks in bones resulting from low bone mass and microarchitectural deterioration characteristic of OSTEOPOROSIS.
Excerpt | Relevance | Reference |
---|---|---|
"Drugs are normally prescribed to treat osteoporosis, especially after surgical treatment of osteoporotic fractures." | 1.91 | Bio-orthogonal engineered peptide: A multi-functional strategy for the gene therapy of osteoporotic bone loss. ( Bai, J; Chu, PK; Gao, A; Ge, G; Geng, D; Liu, X; Wang, G; Wang, H; Wang, Q; Wang, W; Wu, Z; Yu, L, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Wang, W | 1 |
Wang, Q | 1 |
Yu, L | 1 |
Ge, G | 1 |
Liu, X | 1 |
Gao, A | 1 |
Wang, G | 1 |
Wu, Z | 1 |
Bai, J | 1 |
Wang, H | 1 |
Chu, PK | 1 |
Geng, D | 1 |
1 other study available for dihydroxyphenylalanine and Osteoporotic Fractures
Article | Year |
---|---|
Bio-orthogonal engineered peptide: A multi-functional strategy for the gene therapy of osteoporotic bone loss.
Topics: Aged; Dihydroxyphenylalanine; Humans; Osteoporosis; Osteoporotic Fractures; Peptides; Reactive Oxyge | 2023 |